Went public on 7/20/2000 at $12 per share
Filing Range: 3 mil. shares @ $11 to $12
Shares Outstanding: 12.1 mil. shares
Underwriters: Salomon Smith Barney/Stephens Inc./William Blair & Co.
Company Counsel: Dorsey & Whitney LLP
Manager Counsel: Katten Muchin & Zavis
Auditor: Ernst & Young LLP
Develops proprietary vascular sealing devices that allows for rapid sealing of the arterial access sites following a catheterization procedure. The product uses a balloon catheter which is inserted through the introducer sheath that is already in the patient. The inflated balloon serves as a temporary mechanical seal, preventing the flow of blood from the artery. Our procoagulant, which is a proprietary mixture of thrombin, collagen and diluent, is then delivered to the puncture site, stimulating rapid clotting and creating a complete seal of both the arterial puncture and the tissue tract from the artery to the skin surface. With the Duett sealing device, nothing is left behind in the artery, so immediate reaccess of the site, if necessary, is possible, and the potential for infection is minimized.
Olympic Venture Partners
Kirlan Venture Capital Inc.
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 01/01/1997 2 Early Stage 1500.0
2 12/29/1997 3 Expansion 6999.9
3 12/10/1998 5 Expansion 8000.1
(Data in $ millions)
Total Revenues: $1.4
Net Income: -7.9